GlassScriptPhysician profile
Steven J Kernis
NPI 1336103845
$4,295.69
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,319 · 2020: $1,042 · 2021: $412 · 2022: $330 · 2023: $144 · 2024: $48.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,594.34 | 2019 | |
| Boston Scientific Corporation | $914.07 | 2019-2020 | |
| Novo Nordisk INC | $553.22 | 2019-2023 | Wegovy |
| Novartis Pharmaceuticals Corporation | $249.01 | 2019-2024 | |
| Amarin Pharma, INC. | $246.89 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $163.08 | 2019-2022 | |
| Medtronic, INC. | $146.70 | 2021 | |
| Abbvie INC. | $118.60 | 2022 | |
| Irhythm Technologies, INC. | $84.85 | 2022-2023 | Zio Xt Patch |
| Janssen Pharmaceuticals, INC | $55.58 | 2020 | |
| Pfizer INC. | $47.32 | 2019-2021 | |
| Amgen INC. | $43.16 | 2019 | |
| Baxter Healthcare | $28.89 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Medtronic Vascular, INC. | $22.89 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.10 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $12.99 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kernis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.